prescription drug abuse, daniel blaney-koen - slc 2015
TRANSCRIPT
The nation’s opioid epidemic:Are we asking the right questions?
© 2015 American Medical Association. All rights reserved.
A. Are the number of unintentional overdoses and deaths due to opioids going up or down?
B. Are the number of prescriptions for opioids going up or down?
C. Do mandates for prescribers to check prescription drug monitoring programs lower prescribing rates or mortality rates?
D. Do mandates for prescribers to take “pain” or “prescribing” education lower prescribing rates or mortality rates?
E. Why don’t more physicians provide medication assisted treatment?
F. Do you know a physician who has co-prescribed naloxone?
2
© 2015 American Medical Association. All rights reserved.
Drug Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999–2013
% CHANGE2006-2013
+ 17%
+ 184%
Sources: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 20130
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
2006-2013 mortality data
© 2015 American Medical Association. All rights reserved.
4
Drug overdose rates by state
© 2015 American Medical Association. All rights reserved.
5
© 2015 American Medical Association. All rights reserved.
6
© 2015 American Medical Association. All rights reserved. 7
517,000
© 2015 American Medical Association. All rights reserved. 8
© 2015 American Medical Association. All rights reserved. 9
National prescribing trends
• Overall utilization of opioids– 2013: 251,814,805– 2014: 244,457,347
• Growth, opioid utilization– 2014: 2.9% decrease
• Growth, hydrocodone utilization– 2014: 10% decrease
•
© 2015 American Medical Association. All rights reserved. 10
State Growth in opioid utilization (2013-2014) PDMP mandate?
AR 1.3 NoNV 1.3 YesNM 1.0 YesVT -0.6 YesDE -1.1 No – based on judgmentWV -1.3 YesSC -1.4 NoFL -1.6 NoOR -1.9 NoKY -1.9 YesCA -2.3 (ranked 26th) NoUT -2.4 NoTX -3.3 NoMA -3.3 YesTN -3.4 YesOH -4.1 Yes
© 2015 American Medical Association. All rights reserved.
State Age-adjusted drug poisoning death rate (CDC/NCHS, NVSS)
Growth in opioid utilization 2013-2014 (%) (IMS Health)
CA Rate significantly lower than overall US rate -2.3 (ranked 26th)TX Rate significantly lower than overall US rate -3.3MA Rate not significantly different from overall US rate -3.3OR Rate not significantly different from overall US rate -1.9AR Rate not significantly different from overall US rate 1.3FL Rate not significantly different from overall US rate -1.6DE Rate not significantly different from overall US rate -1.1SC Rate not significantly different from overall US rate -1.4VT Rate not significantly different from overall US rate -0.6NM Rate significantly higher than overall US rate 1.0OH Rate significantly higher than overall US rate -4.1KY Rate significantly higher than overall US rate -1.9TN Rate significantly higher than overall US rate -3.4NV Rate significantly higher than overall US rate 1.3UT Rate significantly higher than overall US rate -2.4WV Rate significantly higher than overall US rate -1.3
© 2015 American Medical Association. All rights reserved. 12
So why are mandates still so attractive?
• 244,000,000+• 16,000+
© 2015 American Medical Association. All rights reserved.
• AMA Task Force to Reduce Opioid Abuse– Increase registration and use of PDMPs– Ensure safe, evidence-based prescribing– Support comprehensive pain care; reduce the stigma of pain– Reduce the stigma of substance use disorder; increase access to treatment – Increase access to naloxone, Good Samaritan protections
13
© 2015 American Medical Association. All rights reserved.
March 2015: U.S. Dept. of Health and Human Services
• Opioid prescribing practices to reduce opioid use disorders and overdose
• The expanded use of naloxone, used to treat opioid overdoses• Expanded use of Medication-assisted Treatment (MAT) to reduce
opioid use disorders and overdose
14
© 2015 American Medical Association. All rights reserved. 15
© 2015 American Medical Association. All rights reserved. 16
October 2015: Charleston, West Virginia
“We can’t fight this epidemic without removing stigma.”President Obama, 10/21/2015
© 2015 American Medical Association. All rights reserved. 17
Is this how to reduce the stigma?
• Two-year limit on treatment?• Formularies that restrict types of treatment?• Drug courts that believe in abstinence?• Fail first therapies for MAT?• Threat of involuntary commitment?
© 2015 American Medical Association. All rights reserved. 18
© 2015 American Medical Association. All rights reserved.
States with naloxone access laws, September 2015: Network for Public Health Law
© 2015 American Medical Association. All rights reserved.
States with overdose Good Samaritan laws, September 2015: Network for Public Health Law
© 2015 American Medical Association. All rights reserved.
A. Are the number of unintentional overdoses and deaths due to opioids going up or down?
B. Are the number of prescriptions for opioids going up or down?
C. Do mandates for prescribers to check prescription drug monitoring programs lower prescribing rates or mortality rates?
D. Do mandates for prescribers to take “pain” or “prescribing” education lower prescribing rates or mortality rates?
E. Why don’t more physicians provide medication assisted treatment?
F. Do you know a physician who has co-prescribed naloxone?
21
© 2015 American Medical Association. All rights reserved. 22
For more information:Daniel Blaney-Koen, JD
Senior Legislative AttorneyAdvocacy Resource Center
(312) [email protected]